{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Fukuhara S"],"funding":["National Research Service Award","Medtronic Inc","National Heart, Lung, and Blood Institute","NHLBI NIH HHS","National Institutes of Health","Phil Jenkins and Darlene &amp; Stephen J. Szatmari Funds"],"pagination":["539-547.e1"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7388726"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["162(2)"],"pubmed_abstract":["<h4>Objective</h4>Despite the rapid adoption of transcatheter aortic valve replacement (TAVR) and worldwide interest in its implantation, TAVR valve explantation has not been well described.<h4>Methods</h4>We retrospectively reviewed 1442 consecutive patients who underwent a TAVR procedure between 2011 and 2019, in which TAVR explantation was performed in 15 patients (1.0%). In addition, 2 patients from outside institutions also underwent TAVR explantation at our institution. We reviewed the clinical details of these 17 patients.<h4>Results</h4>The frequency of TAVR explant increased over time from 0 to 1 during the period from 2011 to 2015 to 6 in 2019. The mean age was 73.0 ± 9.3 years. The majority of patients (88.2%) were in New York Heart Association functional class IV heart failure."],"journal":["The Journal of thoracic and cardiovascular surgery"],"pubmed_title":["Surgical explantation of transcatheter aortic bioprostheses: Results and clinical implications."],"pmcid":["PMC7388726"],"funding_grant_id":["T32 HL076123","5T32HL076123"],"pubmed_authors":["Fukuhara S","Deeb GM","Kim KM","Rosati CM","Yang B","Brescia AA","Shiomi S"],"additional_accession":[]},"is_claimable":false,"name":"Surgical explantation of transcatheter aortic bioprostheses: Results and clinical implications.","description":"<h4>Objective</h4>Despite the rapid adoption of transcatheter aortic valve replacement (TAVR) and worldwide interest in its implantation, TAVR valve explantation has not been well described.<h4>Methods</h4>We retrospectively reviewed 1442 consecutive patients who underwent a TAVR procedure between 2011 and 2019, in which TAVR explantation was performed in 15 patients (1.0%). In addition, 2 patients from outside institutions also underwent TAVR explantation at our institution. We reviewed the clinical details of these 17 patients.<h4>Results</h4>The frequency of TAVR explant increased over time from 0 to 1 during the period from 2011 to 2015 to 6 in 2019. The mean age was 73.0 ± 9.3 years. The majority of patients (88.2%) were in New York Heart Association functional class IV heart failure.","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 Aug","modification":"2025-04-03T23:47:39.602Z","creation":"2022-02-09T08:02:03.835Z"},"accession":"S-EPMC7388726","cross_references":{"pubmed":["32037245"],"doi":["10.1016/j.jtcvs.2019.11.139"]}}